Haier Bio-Medical designs, manufactures, and markets biomedical and laboratory equipment for the global market.
KangHui Medical (NYSE: KH) was a leading Chinese orthopedic device manufacturer with products in trauma, spine, and joint reconstruction. Acquired by Medtronic for $816m.
Lee’s Pharmaceuticals is a fully-integrated specialty pharmaceuticals company focused on the China market, with a product portfolio spanning cardiovascular care, infectious disease, dermatology, ophthalmology, oncology, and gynecology.
SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning oncology, infectious disease, and cardiovascular markets.
Shanghai Sundise Traditional Chinese Medicine Co., Ltd. is a leading high-technology corporation specialized in the modernization of Traditional Chinese Medicine (TCM).
Trauson Holdings (HKSE: 0325) was a leading manufacturer of orthopedic products in China. Acquired by Stryker for $764m.
Yestar International (HK: 2393) is a diversified company with a position in imaging and in vitro diagnostics.
Privately held companies at the time of Vivo’s initial investment.